Key terms

About JNJ

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in the interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.

Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
     
52-week range
     
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date

Key terms

Smart score

Latest JNJ news

Today 8:15am ET Balancing Act: Hold Rating on Johnson & Johnson Amid Steady Growth and Legal Challenges by TipRanks Today 7:29am ET JNJ Earnings: Johnson & Johnson’s Q1 Earnings Beat Estimates by TipRanks Today 7:05am ET Options Volatility and Implied Earnings Moves Today, April 16, 2024 by TipRanks Today 5:32am ET Analysts Offer Insights on Healthcare Companies: Johnson & Johnson (JNJ), Amylyx Pharmaceuticals Inc (AMLX) and Rhythm Pharmaceuticals (RYTM) by TipRanks Yesterday 7:45am ET Cantor Fitzgerald Keeps Their Buy Rating on Johnson & Johnson (JNJ) by TipRanks Yesterday 7:00am ET Options Volatility and Implied Earnings Moves This Week, April 15 – April 19, 2024 by TipRanks Yesterday 6:28am ET Mind Medicine initiated with an Outperform at Leerink by TipRanks Yesterday 6:08am ET Integer upgraded to Buy from Neutral at BofA by TipRanks Apr 12 1:37pm ET Buy/Sell: Wall Street’s top 10 stock calls this week by TipRanks Apr 11 9:40am ET DoorDash upgraded, Airbnb downgraded: Wall Street’s top analyst calls by TipRanks Apr 11 8:16am ET Rallybio price target lowered to $11 from $13 at Wedbush by TipRanks Apr 10 4:22pm ET Kenvue initiated with an Underperform at Bernstein by TipRanks Apr 10 4:03pm ET Rallybio to partner with J&J on soultions to reduce risk of FNAIT by TipRanks Apr 08 9:44am ET Ulta upgraded, Skyworks downgraded: Wall Street’s top analyst calls by TipRanks Apr 08 7:37am ET ShockWave Medical downgraded to Hold from Buy at Needham by TipRanks Apr 08 7:04am ET Johnson & Johnson announces presentation of findings on XARELTO by TipRanks Apr 08 4:39am ET ShockWave Medical downgraded to Hold from Buy at Deutsche Bank by TipRanks Apr 07 6:21am ET FDA approves J&J’s CARVYKTI in refractory multiple myeloma by TipRanks Apr 05 9:31am ET M&A News: Johnson & Johnson (NYSE:JNJ) Enters Into $13.1B Shockwave Medical Deal by TipRanks Apr 05 9:20am ET ShockWave Medical downgraded to Hold from Buy at Needham by TipRanks Apr 05 6:38am ET Johnson & Johnson: ShockWave Medical deal to accelerate revenue growth by TipRanks Apr 05 6:35am ET Johnson & Johnson sees ShockWave Medical deal dilutive to EPS in FY24/FY25 by TipRanks Apr 05 6:33am ET Johnson & Johnson to acquire ShockWave Medical for $335.00 per share in cash by TipRanks Apr 05 6:31am ET Johnson & Johnson to acquire ShockWave Medical for $335.00 per share in cash by TipRanks Apr 04 7:11pm ET ShockWave Medical downgraded to Peer Perform from Outperform at Wolfe Research by TipRanks Apr 04 6:01pm ET Johnson & Johnson urges shareholders to reject ‘mini-tender’ offer by TRC by TipRanks Apr 04 7:01am ET Odyssey Therapeutics enters into a collaboration with Jannsen Pharmaceutica by TipRanks Mar 29 3:58pm ET Paging Dr. Nvidia (NASDAQ:NVDA): AI and Healthcare by TipRanks Mar 28 1:57pm ET J&J to pay $75M to settle $6B baby powder lawsuit, Bloomberg reports by TipRanks Mar 28 10:08am ET J&J to pay $75M to settle Mississipi talc lawsuit, Bloomberg says by TipRanks Mar 27 3:50pm ET Judge gives J&J new chance to contest evidence on talc products, Reuters says by TipRanks
Apr 12 8:00am ET 5 Dividend Kings That Yield More Than Vanguard's Top Value ETF by Motley Fool Apr 09 9:51am ET How's AT&T Handling Things? by Motley Fool Apr 09 4:21am ET 3 Dividend Growth Stocks With Yields Above 3% That You Can Buy and Hold for the Next Decade by Motley Fool Apr 08 3:46am ET 2 Dividend Stocks to Buy and Hold Forever by Motley Fool Apr 06 8:15am ET Can a New CEO Fix Boeing? by Motley Fool Apr 01 5:06pm ET Why 3M Stock Was Moving Higher Today by Motley Fool Mar 31 3:10am ET 2024 S&P 500 Bull Market: 2 Unstoppable Growth Stocks to Buy Right Now by Motley Fool Mar 30 5:19am ET 3 Reliable Dividend Growth Stocks With Yields Above 3% That You Can Buy Now and Hold for at Least a Decade by Motley Fool Mar 29 9:00am ET Why Shockwave Medical Stock Rallied as Much as 18% Higher This Week by Motley Fool Mar 28 6:15am ET 3 Dividend Stocks That Are Likely to Raise Their Payouts in April by Motley Fool Mar 22 4:25am ET Want Decades of Passive Income? 2 Stocks to Buy Now. by Motley Fool Mar 21 5:02am ET Should You Buy 3M Before April 1? by Motley Fool Mar 16 8:15am ET Meet the "Magnificent Seven" Stock That Pays More Dividends Than Any Other U.S.-Based Company by Motley Fool Mar 16 3:55am ET Johnson & Johnson Stock Is Great. Here's Why You Shouldn't Buy It. by Motley Fool Mar 13 5:21am ET 3 No-Brainer Stocks to Buy With $300 Right Now by Motley Fool Mar 12 6:53am ET 2 High-Yield Dow Jones Dividend Stocks to Buy Now and Hold Forever by Motley Fool Mar 11 5:35am ET 3 Dividend Kings of Healthcare Stocks to Buy Hand Over Fist in March by Motley Fool

No recent press releases are available for JNJ

JNJ Financials

1-year income & revenue

Key terms

JNJ Forecasts

analyst rating

  • buy
  • hold
  • sell

We're sorry, but this
information is
temporarily unavailable.

1-year stock price forecast

JNJ Competitors

$ Market cap P/E ratio $ Price 1d change 52-week range

Key terms

Latest investing news

Tim Wren, chief commercial officer for BSI Group, right, presents Kristalina Georgieva, chief executive officer of the World Bank Group, second right, with ISO 20121 certification for sustainable event management at an event during the spring meetings of the International Monetary Fund (IMF) and World Bank in Washington, DC, US, on Monday, April 15, 2024. The IMF and World Bank spring meetings in Washington are expected to draw thousands of delegates, observers and journalists from the fund's 190 member countries. Photographer: Samuel Corum/Bloomberg via Getty Images
Samuel Corum/Bloomberg/Getty Images
Geopolitical strife is roiling Wall Street. Here’s what investors are watching
Donald Trump might no longer own a majority of TMTG after a new public share offering.
Joe Raedle/Getty Images
Trump stock tanks after announcing massive share sale
1040 US Individual Income Tax Return Form
Nora Carol Photography/Moment RF/Getty Images
Three ways investors can minimize their tax payments
People walk past the New York Stock Exchange (NYSE) on April 10, 2024 in New York City.
Spencer Platt/Getty Images
Dow closes nearly 500 points lower on fears of potential Iranian attack on Israel